幽門螺旋桿菌診斷市場：按檢測類型、最終用戶和地區分類

Helicobacter Pylori Diagnostics Market, By Test Type, By End Users, By Geography

出版日期: 2026年05月27日 | 出版商:

Coherent Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

幽門螺旋桿菌診斷市場預計在 2026 年達到 9.8187 億美元，預計到 2033 年將達到 195 億美元。預計從 2026 年到 2033 年，該市場將以 10.04% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	9.8187億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	10.04%	2033年市場規模預測：	195萬美元

幽門螺旋桿菌是一種寄生於人類胃黏膜的細菌。幽門螺旋桿菌產生的化學物質會導致胃部炎症，進而發展為消化性潰瘍和胃癌。幽門螺旋桿菌感染可透過一些簡單而準確的檢測方法來檢測，例如呼吸檢測、血液檢測、內視鏡檢查和糞便檢驗。根據樣本製備方式的不同，幽門螺旋桿菌的診斷方法可分為「免疫檢測、快速尿素酶試驗和組織活體組織切片；非侵入性檢測包括糞便抗原檢測、血清學檢測和尿素酶呼吸檢測。新興國家感染率的上升以及對即時檢測的高需求是推動幽門螺旋桿菌診斷市場成長的主要因素。

市場動態

為了獲得競爭優勢，市場新進業者正投資開發即時檢測（POC）和高精度診斷產品。例如，2017年，Exaleza Bioscience推出了用於檢測幽門螺旋桿菌的「Automated BreathID Hp Lab Urea Breath Testing System」。本系統為即時檢測產品，對幽門螺旋桿菌的敏感度和特異性均高達99%。此外，各公司正致力於透過非內部成長策略來強化產品系列。例如，雅培公司收購了即時診斷的全球領導者Alere Inc.，以拓展產品系列和企業發展。此次收購使雅培得以進入Alere的快速診斷市場，包括幽門螺旋桿菌檢測試劑盒。然而，目前診斷方法的局限性預計將限制幽門螺旋桿菌診斷市場的成長。例如，接受質子幫浦阻斷劑治療的患者不能進行尿素呼吸檢測和糞便抗原試驗。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、產品召回、區域前景以及主要參與者採取的競爭策略的重要見解。
本研究基於以下參數分析了全球幽門螺旋桿菌診斷市場的主要參與者：公司概況、財務表現、產品系列、企業發展區域、分銷策略、關鍵發展、策略和未來計劃。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、分銷管道創新、市場擴張和行銷策略做出明智的決策。
這份「全球幽門螺旋桿菌診斷市場報告」旨在為業內廣泛的經銷商提供服務，包括投資者、產品製造商、幽門螺旋桿菌診斷測試和設備的分銷商和相關人員、研究和諮詢公司、新參與企業和金融分析師。
在幽門螺旋桿菌診斷市場分析中使用的各種策略矩陣為相關人員提供了做出適當策略決策的關鍵資訊。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories Inc.
- Diasorin SPA
- Quidel Corporation
- F. Hoffmann-La Roche Ltd.（Ventana Medical Systems, Inc.）
- Meridian Bioscience, Inc.
- Exalenz Bioscience Ltd.
- Abbott Laboratories
- Cardinal Health, Inc.
- Halyard Health, Inc.

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1874

Helicobacter Pylori Diagnostics Market is estimated to be valued at USD 981.87 Mn in 2026 and is expected to reach USD 1.95 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.04% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 981.87 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	10.04%	2033 Value Projection:	USD 1.95 Mn

Helicobacter pylori is a bacteria that resides on the lining of human stomach. Helicobacter produces chemicals, causing inflammation of stomach, which progresses to peptic ulcer or gastric cancer. Helicobacter pylori infection can be detected by simple and accurate tests such as breath test, blood tests, endoscopy, and stool tests. Based on the sample preparation, helicobacter pylori diagnostic assays are segmented into invasive methods, which includes immunoassay, rapid urease test, and histology, and Non-invasive methods, which includes stool antigen assay, serology test and urease breath test. Increasing infection prevalence in emerging economies and high demand for point-of-care testing are major factors driving growth of Helicobacter pylori diagnostics market.

Market Dynamics

Market players are investing in developing point-of-care and accurate diagnostics products to gain competitive advantage. For instance, in 2017, Exaleza Bioscience launched Automated BreathID Hp Lab Urea Breath Testing System for detection of Helicobacter pylori. The system is point-of-care, with 99% sensitivity and specificity for H. pylori. Furthermore, companies are focusing enhancing product portfolio through inorganic growth strategies. For instance, Abbott Laboratories acquired Alere Inc., the global leader in point of care diagnostics, in order to expand its product portfolio and geographic presence. With this acquisition, Abbott could access to Alere's rapid diagnostics segment, which includes H. pylori detection kits. However, limitations associated with the currently available diagnostic assays are expected to restrain the Helicobacter pylori diagnostics market. For instance, urea breath test and stool antigen test cannot be used in patients undergoing proton pump inhibitors treatment.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, product recalls, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global helicobacter pylori diagnostics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion, and marketing tactics.
The global Helicobacter pylori diagnostics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of helicobacter pylori diagnostic tests/devices, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the Helicobacter pylori diagnostics market would provide stakeholders vital inputs to make strategic decisions accordingly

Market Segmentation

By Test Type (Revenue, USD Mn, 2021-2033)
- Invasive
- Immunoassay
- Rapid Urease Test
- Histology
- Non-invasive
- Stool Antigen Assay
- Serology Tests
- Urea Breath Test
By End Users (Revenue, USD Mn, 2021-2033)
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories Inc.
- Diasorin S.P.A.
- Quidel Corporation
- Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.)
- Meridian Bioscience, Inc.
- Exalenz Bioscience Ltd.
- Abbott Laboratories
- Cardinal Health, Inc.
- Halyard Health, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By End Users
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Helicobacter Pylori Diagnostics Market, By Test Type, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Invasive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  - Immunoassay
  - Rapid Urease Test
  - Histology
Non-invasive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  - Stool Antigen Assay
  - Serology Tests
  - Urea Breath Test

5. Helicobacter Pylori Diagnostics Market, By End Users, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

6. Helicobacter Pylori Diagnostics Market, By Region, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Million)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Thermo Fisher Scientific, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Bio-Rad Laboratories Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Diasorin S.P.A.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Quidel Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.)
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Meridian Bioscience, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Exalenz Bioscience Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cardinal Health, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Halyard Health, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
  - Analyst Views